Increased circulating intercellular adhesion molecule-1 levels in type II diabetic patients: The possible role of metabolic control and oxidative stress

Blood levels of the circulating form of the integrin intercellular adhesion molecule-1 (ICAM-1), malondialdehyde (MDA), and hemoglobin A 1c(HbA 1c) were studied at baseline and 3 months after improved metabolic control in 25 type II diabetic patients without signs of macroangiopathy, and were compar...

Full description

Saved in:
Bibliographic Details
Published inMetabolism, clinical and experimental Vol. 45; no. 4; pp. 498 - 501
Main Authors Ceriello, Antonio, Falleti, Edmondo, Bortolotti, Nadia, Motz, Enrico, Cavarape, Alessandro, Russo, Assunta, Gonano, Fabio, Bartoli, Ettore
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.04.1996
Elsevier
Subjects
Online AccessGet full text
ISSN0026-0495
1532-8600
DOI10.1016/S0026-0495(96)90226-7

Cover

More Information
Summary:Blood levels of the circulating form of the integrin intercellular adhesion molecule-1 (ICAM-1), malondialdehyde (MDA), and hemoglobin A 1c(HbA 1c) were studied at baseline and 3 months after improved metabolic control in 25 type II diabetic patients without signs of macroangiopathy, and were compared with those in 15 matched healthy normal controls. Circulating ICAM-1 and MDA levels were increased in diabetic patients, both at baseline and 3 months later. However, with improving metabolic control HbA 1c, circulating ICAM-1, and MDA significantly decreased. A significant correlation between circulating ICAM-1, HbA 1c, and MDA was found in diabetic patients at each time. Multiple regression analysis considering circulating ICAM-1 as the dependent variable and HbA 1c and MDA as independent variables, showed a significant correlation between the three variables at each time. Similar correlations were found in control subjects. These data show increased levels of circulating ICAM-1 in type II diabetic patients, independent of the presence of macroangiopathy. Moreover, these results suggest that oxidative stress and metabolic control might participate in determining increased circulating ICAM-1 levels in both type II diabetic patients and normal subjects.
Bibliography:S30
9621917
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0026-0495
1532-8600
DOI:10.1016/S0026-0495(96)90226-7